Her doctoral research investigated the mechanisms underlying T-cell mediated neuroprotection in injured central nervous system tissue.

[2] Following her PhD, Fisher started her pioneering work as a postdoctoral research fellow on the application of formal verification methods to analyse executable mechanic models of cellular processes, first with David Harel at the Weizmann Institute and subsequently with Thomas Henzinger at the École Polytechnique Fédérale de Lausanne, Switzerland.

[6] Practical applications include improved therapies for Acute Myeloid Leukaemia (joint work with Astra Zeneca)[7] and Breast Cancer.

It has a user-friendly interface designed to be accessible to non-computing experts, biologists and clinicians, as well as for drug discovery[12] in the biotech and big pharma sectors.

Research is focussed on understanding how cancers evolve through the identification of molecular mechanisms that underpin cell-fate decision programs during both normal development and disease.